| Citation: |
YANG Meng, DAI Dianlu, LIU Licheng. Expression and Clinical Significance of Artemin Protein in Triple-negative and Nontriple-negative Breast Cancer Tissues[J]. Cancer Research on Prevention and Treatment, 2016, 43(6): 479-482. DOI: 10.3971/j.issn.1000-8578.2016.06.009
|
To investigate the expression of Artemin protein in triple-negative breast cancer (TNBC) and non-triple-negative breast cancer (non-TNBC) tissues, and to further explore its relationship with clinical pathology and the prognosis of tumor, to provide powerful evidence for judging biological behaviour and evaluating the prognosis.
According to the criteria, 240 cases of breast cancer (120 cases of TNBC, 120 cases of non-TNBC, respectively) were selected randomly and admitted to Cangzhou Central Hospital of Hebei Medical University from July 2005 to July 2009. The expression of Artemin was detected in tumor tissues. All data were analyzed using t test and chi-square test, and the survival of patients was analyzed using the life table and Kaplan-Meier curves. The COX proportional hazards model was also used for the prognosis.
The positive expression rate of Artemin protein was 61.7％(148/240) . The positive rate of Artemin in TNBC tissues was higher than that in non-TNBC tissues [82.5%(99/120) vs. 41.0%(49/120) ]. The survival rates of 1-, 3-, 5-year in the groups of TNBC with positive Artemin, TNBC without Artemin, non-TNBC with positive Artemin, and non-TNBC without Artemin were 93.0%, 78.0%, 50.0% vs. 100.0%, 89.0%, 79.0% vs. 98.0%, 89.0%, 89.0% vs. 99.0%, 97.0%, 97.0%, respectively(P<0.05) .
Artemin is clearly expressed higher in TNBC than non-TNBC tissues, and is one of the important indicators for the prognosis of breast cancer, with great value for research.
| [1] |
Thike AA, Cheok PY, Jara-Lazaro AR, et al. Triple-negative breast cancer: clinicpathological characteristics and relationship with basal-like breast cancer[J]. Mod Pathol, 2010, 23(1) : 123-33.
|
| [1] |
Thike AA, Cheok PY, Jara-Lazaro AR, et al. Triple-negative breast cancer: clinicpathological characteristics and relationship with basal-like breast cancer[J]. Mod Pathol, 2010, 23(1): 123-33.
|
| [2] |
马睿锐, 陈琳, 陈欣, 等. 183例三阴性乳腺癌临床病理特征及生存分析[J]. 中华普通外科杂志, 2012, 27(3) : 230-3.
Ma RR, Chen L, Chen X, et al. Clinicopathologic characteristics and survival analysis of 183 cases of triple negative breast cancer[J]. Zhonghua Pu Tong Wai Ke Za Zhi, 2012, 27(3) : 230-3.
|
| [2] |
Ma RR, Chen L, Chen X, et al. Clinicopathologic characteristics and survival analysis of 183 cases of triple negative breast cancer[J]. Zhonghua Pu Tong Wai Ke Za Zhi, 2012, 27(3): 230-3. [马睿锐, 陈琳, 陈欣, 等. 183例三阴性乳腺癌临床病理特征及 生存分析[J]. 中华普通外科杂志, 2012, 27(3): 230-3.]
|
| [3] |
Banerjee A, Wu ZS, Qian P, et al. ARTEMIN synergizes with TWIST1 to promote metastasis and poor survival outcome in patients with ER negative mammary carcinoma[J]. Breast Cancer Res, 2011, 13(6) : R112.
|
| [3] |
Banerjee A, Wu ZS, Qian P, et al. ARTEMIN synergizes with TWIST1 to promote metastasis and poor survival outcome in patients with ER negative mammary carcinoma[J]. Breast Cancer Res, 2011, 13(6): R112.
|
| [4] |
Goldhirsch A, Wood WC, Coates AS, et al．Strategies for subtypes-dealing with the diversity of breast cancer: highlights of the St. Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2011[J]. Ann Oncol, 2011, 22(8): 17 36-47.
|
| [4] |
Goldhirsch A, Wood WC, Coates AS, et al．Strategies for subtypes-dealing with the diversity of breast cancer: highlights of the St. Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2011[J]. Ann Oncol, 2011, 22(8) : 1736-47.
|
| [5] |
Edge SB, Compton CC. The American Joint Committee on Cancer: the 7th edition of the AJCC cancer staging manual and the future of TNM[J]. Ann Surg Oncol, 2010, 17(6): 1471-4.
|
| [5] |
Edge SB, Compton CC. The American Joint Committee on Cancer: the 7th edition of the AJCC cancer staging manual and the future of TNM[J]. Ann Surg Oncol, 2010, 17(6) : 1471-4.
|
| [6] |
Zhang Rui, Chen HJ, Wei B, et al. Reproducibility of the Nottingham modification of the Scarff-Bloom-Richardson histological grading system and the complimentary value of Ki-67 to the system[J]. Chin Med J (Engl), 2013, 123(15) : 1976-82.
|
| [6] |
Zhang Rui, Chen HJ, Wei B, et al. Reproducibility of the Nottingham modification of the Scarff-Bloom-Richardson histological grading system and the complimentary value of Ki-67 to the system[J]. Chin Med J (Engl), 2013, 123(15): 1976-82.
|
| [7] |
Gao BY, Liu Y, Xia LP, et al. Comparison of clinicopathological features and prognosis in triple-negative and non triple·-negative breast cancer[J]. Zhong Liu Fang Zhi Yan Jiu, 2013, 40(8): 786-8. [高炳玉, 刘玉, 夏立平, 等. 三阴性乳腺癌和非三阴性乳腺癌 临床特征及预后的比较分析[J]. 肿瘤防治研究, 2013, 40(8): 78 6-8.]
|
| [7] |
高炳玉, 刘玉, 夏立平, 等. 三阴性乳腺癌和非三阴性乳腺癌临床特征及预后的比较分析[J]. 肿瘤防治研究, 2013, 40(8) : 786-8.
Gao BY, Liu Y, Xia LP, et al. Comparison of clinicopathological features and prognosis in triple-negative and non triple·-negative breast cancer[J]. Zhong Liu Fang Zhi Yan Jiu, 2013, 40(8) : 786-8.
|
| [8] |
张庆慧, 徐嘉雯. 提高对基底细胞样乳腺癌和三阴性乳腺癌的认识[J]. 临床与实验病理学杂志, 2008, 24(2) : 131-6.
Zhang QH, Xu JW. Increase the consensus of the basal cells breast cancer and three negative breast cancer[J]. Lin Chuang Yu Shi Yan Bing Li Xue Za Zhi, 2008, 24(2) : 131-6.
|
| [8] |
Zhang QH, Xu JW. Increase the consensus of the basal cells breast cancer and three negative breast cancer[J]. Lin Chuang Yu Shi Yan Bing Li Xue Za Zhi, 2008, 24(2): 131-6. [张庆慧, 徐嘉雯. 提 高对基底细胞样乳腺癌和三阴性乳腺癌的认识[J]. 临床与实验 病理学杂志, 2008, 24(2): 131-6.]
|
| [9] |
Meng LX, Chi YH, Wang XX, et al. Neurotrophic artemin promotes motility and invasiveness of MIA PaCa-2 pancreatic cancer cells[J]. Asian Pac J Cancer Prev, 2012, 13(5): 1793-7.
|
| [9] |
Meng LX, Chi YH, Wang XX, et al. Neurotrophic artemin promotes motility and invasiveness of MIA PaCa-2 pancreatic cancer cells[J]. Asian Pac J Cancer Prev, 2012, 13(5) : 1793-7.
|
| [10] |
Banerjee A, Wu ZS, Qian PX, et al. ARTEMIN promotes de novo angiogenesis in ER negative mammary carcinoma through activation of TWIST1-VEGF-A signaling[J]. PLoS One, 2012, 7(11) : e50098.
|
| [10] |
Banerjee A, Wu ZS, Qian PX, et al. ARTEMIN promotes de novo angiogenesis in ER negative mammary carcinoma through activation of TWIST1-VEGF-A signaling[J]. PLoS One, 2012, 7( 11): e50098.
|
| [12] |
Li CY, Wang P, Zhang S, et al. Clinicopathological features and prognosis of triple-negative breast cancer[J]. Zhonghua Zhong Liu Za Zhi, 2013, 35(6) : 463-7.
|
| [12] |
Li CY, Wang P, Zhang S, et al. Clinicopathological features and prognosis of triple-negative breast cancer[J]. Zhonghua Zhong Liu Za Zhi, 2013, 35(6): 463-7. [李春艳, 王培, 张晟, 等. 三阴性乳腺 癌的临床病理特征和预后分析[J]. 中华肿瘤杂志, 2013, 35(6): 46 3-7.]
|
| [13] |
Chu J. Clinicopathological features and prognosis factors of triplenegative breast cancer[J]. Xian Dai Zhong Liu Xue, 2011, 19(5) : 921-4.
李春艳, 王培, 张晟, 等. 三阴性乳腺癌的临床病理特征和预后分析[J]. 中华肿瘤杂志, 2013, 35(6) : 463-7.
|
| [14] |
Qiu JD, Ma ZH, Ma JH, et al. Comparison of clinicopathological features and prognosis in triple-negative and non triple-negative breast cancer[J]. Zhonghua Nei Fen Mi Wai Ke Za Zhi, 2012, 6(5) : 313-7.
储君. 三阴性乳腺癌的临床病理特征及预后因素分[J]. 现代肿瘤医学, 2011, 19(5) : 921-4.
|
| [13] |
Chu J. Clinicopathological features and prognosis factors of triplenegative breast cancer[J]. Xian Dai Zhong Liu Xue, 2011, 19(5): 92 1-4. [储君. 三阴性乳腺癌的临床病理特征及预后因素分[J]. 现代肿瘤医学, 2011, 19(5): 921-4.]
|
| [14] |
Qiu JD, Ma ZH, Ma JH, et al. Comparison of clinicopathological features and prognosis in triple-negative and non triple-negative breast cancer[J]. Zhonghua Nei Fen Mi Wai Ke Za Zhi, 2012, 6( 5): 313-7. [邱镜丹, 马振海, 马金辉, 等. 三阴与非三阴性乳 腺癌临床病理特征与预后比较[J]. 中华内分泌外科杂志, 2012, 6( 5): 313-7.]
|
| [15] |
Dent R, Trudeau M, Pritchard KI, et al. Triple-negative breast cancer: clinical features and patterns of recurrence[J]. Clin Cancer Res, 2007, 13(15Pt1) : 4429-34.
邱镜丹, 马振海, 马金辉, 等. 三阴与非三阴性乳腺癌临床病理特征与预后比较[J]. 中华内分泌外科杂志, 2012, 6(5) : 313-7.
|
| [15] |
Dent R, Trudeau M, Pritchard KI, et al. Triple-negative breast cancer: clinical features and patterns of recurrence[J]. Clin Cancer Res, 2007, 13(15Pt1): 4429-34.
|
This work is licensed under a Creative Commons Attribution 3.0 License.
Copyright © Editorial Department of Cancer Prevention Research 鄂公网安备 42011102005013号 鄂ICP备2022015867号
Supported by: Beijing Renhe Information Technology Co., Ltd. 
DownLoad: